Carlton Kevin Pascoe's most recent trade in National Health Investors, Inc. was a trade of 8,500 Stock Option (Right to Buy) 2024 done . Disclosure was reported to the exchange on Feb. 23, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| National Health Investors Inc | Kevin Carlton Pascoe | Chief Investment Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2026 | 8,500 | 0 | - | - | Stock Option (Right to Buy) 2024 | |
| National Health Investors Inc | Kevin Carlton Pascoe | Chief Investment Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.76 per share. | 23 Feb 2026 | 8,500 | 74,765 (0%) | 0% | 57.8 | 490,960 | Common Stock |
| National Health Investors Inc | Kevin Carlton Pascoe | Chief Investment Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 90.03 per share. | 23 Feb 2026 | 6,409 | 68,356 (0%) | 0% | 90.0 | 577,002 | Common Stock |
| National Health Investors Inc | Kevin Carlton Pascoe | Chief Investment Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2026 | 15,000 | 0 | - | - | Stock Option (Right to Buy) 2025 | |
| National Health Investors Inc | Kevin Carlton Pascoe | Chief Investment Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 73.34 per share. | 11 Feb 2026 | 15,000 | 79,728 (0%) | 0% | 73.3 | 1,100,100 | Common Stock |
| National Health Investors Inc | Kevin Carlton Pascoe | Chief Investment Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.25 per share. | 11 Feb 2026 | 13,463 | 66,265 (0%) | 0% | 88.3 | 1,188,110 | Common Stock |
| National Health Investors Inc | Kevin Carlton Pascoe | Chief Investment Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 82.12 per share. | 30 Jan 2026 | 13,602 | 64,728 (0%) | 0% | 82.1 | 1,116,996 | Common Stock |
| National Health Investors Inc | Kevin Carlton Pascoe | Chief Investment Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.76 per share. | 30 Jan 2026 | 8,500 | 78,330 (0%) | 0% | 57.8 | 490,960 | Common Stock |
| National Health Investors Inc | Kevin Carlton Pascoe | Chief Investment Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2026 | 8,500 | 0 | - | - | Stock Option (Right to Buy) 2024 | |
| National Health Investors Inc | Kevin Carlton Pascoe | Chief Investment Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2026 | 8,500 | 0 | - | - | Stock Option (Right to Buy) 2023 | |
| National Health Investors Inc | Kevin Carlton Pascoe | Chief Investment Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 54.73 per share. | 30 Jan 2026 | 8,500 | 69,830 (0%) | 0% | 54.7 | 465,205 | Common Stock |
| National Health Investors Inc | Kevin Carlton Pascoe | Chief Investment Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) 2025 | |
| National Health Investors Inc | Kevin Carlton Pascoe | Chief Investment Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) 2025 | |
| National Health Investors Inc | Kevin Carlton Pascoe | Chief Investment Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) 2025 | |
| National Health Investors Inc | Kevin Carlton Pascoe | Chief Investment Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 5,500 | 61,330 (0%) | 0% | 0 | Common Stock | |
| National Health Investors Inc | Kevin Carlton Pascoe | Chief Investment Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.63 per share. | 23 Aug 2024 | 101,230 | 55,830 (0%) | 0% | 78.6 | 7,959,715 | Common Stock |
| National Health Investors Inc | Kevin Carlton Pascoe | Chief Investment Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2024 | 18,334 | 0 | - | - | Stock Options (Right to Buy) 2-25-2021 | |
| National Health Investors Inc | Kevin Carlton Pascoe | Chief Investment Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 53.41 per share. | 23 Aug 2024 | 18,334 | 148,560 (0%) | 0% | 53.4 | 979,219 | Common Stock |
| National Health Investors Inc | Kevin Carlton Pascoe | Chief Investment Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 69.20 per share. | 23 Aug 2024 | 18,334 | 94,893 (0%) | 0% | 69.2 | 1,268,713 | Common Stock |
| National Health Investors Inc | Kevin Carlton Pascoe | Chief Investment Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2024 | 18,334 | 0 | - | - | Stock Option (Right to buy) 2022 | |
| National Health Investors Inc | Kevin Carlton Pascoe | Chief Investment Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2024 | 18,333 | 0 | - | - | Stock Options (Right to Buy) 2-25-2021 | |
| National Health Investors Inc | Kevin Carlton Pascoe | Chief Investment Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2024 | 18,333 | 0 | - | - | Stock Options (Right to Buy) 2-25-2021 | |
| National Health Investors Inc | Kevin Carlton Pascoe | Chief Investment Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 53.41 per share. | 23 Aug 2024 | 18,333 | 130,226 (0%) | 0% | 53.4 | 979,166 | Common Stock |
| National Health Investors Inc | Kevin Carlton Pascoe | Chief Investment Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 69.20 per share. | 23 Aug 2024 | 18,333 | 76,559 (0%) | 0% | 69.2 | 1,268,644 | Common Stock |
| National Health Investors Inc | Kevin Carlton Pascoe | Chief Investment Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 69.20 per share. | 23 Aug 2024 | 18,333 | 58,226 (0%) | 0% | 69.2 | 1,268,644 | Common Stock |
| National Health Investors Inc | Kevin Carlton Pascoe | Chief Investment Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2024 | 18,333 | 0 | - | - | Stock Option (Right to buy) 2022 | |
| National Health Investors Inc | Kevin Carlton Pascoe | Chief Investment Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.76 per share. | 23 Aug 2024 | 8,500 | 157,060 (0%) | 0% | 57.8 | 490,960 | Common Stock |
| National Health Investors Inc | Kevin Carlton Pascoe | Chief Investment Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 54.73 per share. | 23 Aug 2024 | 8,500 | 111,893 (0%) | 0% | 54.7 | 465,205 | Common Stock |
| National Health Investors Inc | Kevin Carlton Pascoe | Chief Investment Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 54.73 per share. | 23 Aug 2024 | 8,500 | 103,393 (0%) | 0% | 54.7 | 465,205 | Common Stock |
| National Health Investors Inc | Kevin Carlton Pascoe | Chief Investment Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2024 | 8,500 | 0 | - | - | Stock Option (Right to Buy) 2024 | |
| National Health Investors Inc | Kevin Carlton Pascoe | Chief Investment Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2024 | 8,500 | 0 | - | - | Stock Option (Right to Buy) 2023 | |
| National Health Investors Inc | Kevin Carlton Pascoe | Chief Investment Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2024 | 8,500 | 0 | - | - | Stock Option (Right to Buy) 2023 | |
| National Health Investors Inc | Carlton Kevin Pascoe | Chief Investment Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 8,500 | 8,500 | - | - | Stock Option (Right to Buy) 2024 | |
| National Health Investors Inc | Kevin Pascoe Carlton | Chief Investment Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 8,500 | 8,500 | - | - | Stock Option (Right to Buy) 2024 | |
| National Health Investors Inc | Kevin Carlton Pascoe | Chief Investment Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 8,500 | 8,500 | - | - | Stock Option (Right to Buy) 2024 | |
| National Health Investors Inc | Carlton Pascoe Kevin | Chief Investment Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 3,000 | 39,893 (0%) | 0% | 0 | Common Stock | |
| National Health Investors Inc | Kevin Carlton Pascoe | Chief Investment Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 4,000 | 36,893 (0%) | 0% | 0 | Common Stock | |
| National Health Investors Inc | Kevin Carlton Pascoe | Chief Investment Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2023 | 8,500 | 8,500 | - | - | Stock Option (Right to Buy) 2023 | |
| National Health Investors Inc | Kevin Carlton Pascoe | Chief Investment Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2023 | 8,500 | 8,500 | - | - | Stock Option (Right to Buy) 2023 | |
| National Health Investors Inc | Kevin Carlton Pascoe | Chief Investment Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2023 | 8,500 | 8,500 | - | - | Stock Option (Right to Buy) 2023 | |
| National Health Investors Inc | Kevin Carlton Pascoe | Chief Investment Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Aug 2022 | 18,333 | 0 | - | - | Stock Option (Right to buy) 2022 | |
| National Health Investors Inc | Kevin Carlton Pascoe | Chief Investment Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 53.41 per share. | 26 Aug 2022 | 18,333 | 48,958 (0%) | 0% | 53.4 | 979,166 | Common Stock |
| National Health Investors Inc | Kevin Carlton Pascoe | Chief Investment Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 67.10 per share. | 26 Aug 2022 | 16,065 | 32,893 (0%) | 0% | 67.1 | 1,077,962 | Common Stock |
| National Health Investors Inc | Kevin Carlton Pascoe | Chief Investment Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 18,334 | 18,334 | - | - | Stock Option (Right to buy) 2022 | |
| National Health Investors Inc | Kevin Carlton Pascoe | Chief Investment Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 18,333 | 18,333 | - | - | Stock Option (Right to buy) 2022 | |
| National Health Investors Inc | Kevin Carlton Pascoe | Chief Investment Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 18,333 | 18,333 | - | - | Stock Option (Right to buy) 2022 |